Table 2.
Irinotecan/temozolomide treatment for recurrent Ewing sarcoma: comparison of 5 day and 10 day schedules of administration
| Irinotecan dose schedule | |||
|---|---|---|---|
| Daily x 5 days x 2 weeks (10 doses) | Daily x 5 days x 1 week (5 doses) | ||
| Patients | Objective responses | Patients | Objective responses |
| 89 | 47 (53%) | 180 | 52 (29%) |